SHBG and polycystic ovary syndrome: This fact can be explained by insulin resistance and hyperinsulinemia in overweight/obese patients with persistent anovulation and PCOS, which augments ovarian/adrenal androgen production and SHBG suppression, thereby increasing androgen bioavailability (7, 22).